B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure

Míreanna comhchosúla

• Baseline cellular and molecular characteristics of synovial tissue and relation with TNFI response. Results from the pathobiology of the early arthritis cohort (PEAC)
  de réir: Ribera, G, et al.
  Foilsithe / Cruthaithe: (2019)
• Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
  de réir: Rivellese, F, et al.
  Foilsithe / Cruthaithe: (2022)
• Synovial cell infiltration in acpa-ve patients displays similar signatures to other seronegative inflammatory arthritis. results from the pathobiology of early arthritis cohort (PEAC)
  de réir: Lliso-Ribera, G, et al.
  Foilsithe / Cruthaithe: (2018)
• Rituximab versus tocilizumab and B-cell status in TNF-alpha inadequate-responder rheumatoid arthritis patients: the R4-RA RCT
  de réir: Humby, F, et al.
  Foilsithe / Cruthaithe: (2022)
• A lymphoid pathotype at baseline, in early inflammatory arthritis, significantly associates with requirement for biologic therapy at 12 months follow up: results from the pathobiology of early arthritis cohort
  de réir: Ribera, G, et al.
  Foilsithe / Cruthaithe: (2018)